Hims & Hers Health Inc

2026-08-13 20:07; UTC

Hims & Hers Health Inc shares are lower amid an investigation into potential corporate wrongdoing related to a Federal Trade Commission lawsuit.

2026-08-12 19:41; UTC

Hims & Hers Health Inc. faces scrutiny over cautious peptide outlook and ongoing investigations into customer data sharing, contributing to a decline in shares today.

2026-08-11 19:51; UTC

Hims & Hers Health Inc shares are lower amid broader sector declines following a mixed earnings report and concerns over execution risks.

2026-08-10 23:41; UTC

Hims & Hers Health reported a net loss of $86.3 million in Q2, contributing to a decline in share price during after-market trading.

2026-08-07 19:26; UTC

Hims & Hers Health Inc. shares are trading higher, reflecting strong intraday momentum, despite a slight pullback from earlier session highs amid falling Treasury yields.

2026-08-06 19:16; UTC

Hims & Hers Health is under investigation amid ongoing legal scrutiny. Shares are lower today despite a significant investment and the launch of the Hers App.

2026-08-04 19:22; UTC

Hims & Hers Health is higher as an investigation into potential claims is announced, following a lawsuit over customer medical information sharing.

2026-08-03 23:41; UTC

Hims & Hers Health shares are higher in after-market trading, following positive growth insights despite facing a lawsuit from the Federal Trade Commission.

2026-07-31 19:36; UTC

Hims & Hers Health Inc is trading higher amid social media discussions about potential undervaluation, despite facing a lawsuit over user health data practices.

2026-07-30 20:11; UTC

Hims & Hers Health Inc shares are higher today amid high trading volume. Broader economic data showed mixed signals, contributing to market volatility.

2026-07-29 23:16; UTC

Hims & Hers Health shares declined in after-market trading amid legal challenges from the FTC over alleged privacy violations and a securities fraud investigation.

2026-07-28 23:41; UTC

Hims & Hers Health shares declined in after-market trading, remaining near the lower end of their one-month range amid broader market pressures from Asian tech losses.

2026-07-27 20:03; UTC

Hims & Hers Health shares rise amid FDA committee's endorsement of peptides, seen as a significant step toward market access for treatments.

2026-07-24 23:16; UTC

Hims & Hers Health Inc. shares rose after-hours following positive votes from an FDA/HHS panel on six peptides, with a final decision expected in up to 12 months.

2026-07-23 23:26; UTC

Hims & Hers Health Inc shares are higher after an FDA advisory panel recommended easing restrictions on a popular peptide and Canaccord reiterated a Buy rating.

2026-07-22 23:16; UTC

Hims & Hers Health shares declined to about $31.66 after mixed options sentiment, with calls outpacing puts amid lighter trading volume.

2026-07-21 17:31; UTC

Hims & Hers Health Inc shares are declining amid an investigation into potential wrongdoing and concerns over FDA approval of key peptides.

2026-07-20 18:37; UTC

Hims & Hers Health Inc. is trading higher amid broader market dynamics, despite earlier pulling back from a session high.